Achillion Pharma (ACHN) Announces Presentation of Odalasvir, AL-335 and Simeprevir Phase 2b Data
Go back to Achillion Pharma (ACHN) Announces Presentation of Odalasvir, AL-335 and Simeprevir Phase 2b Data| Achillion Pharmaceuticals, Inc. (AMEX: ACHN) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $10.95 | |||
| Open | $0.79 | 52 Week Low | $3.78 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $-0.63 | |||
| Volume | 257,187 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 145.74 +0.97 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.77 | 52 Week High | $126.07 | |||
| Open | $144.98 | 52 Week Low | $94.28 | |||
| Day High | $145.80 | P/E | 30.30 | |||
| Day Low | $143.13 | EPS | $4.81 | |||
| Volume | 9,887,485 | |||||
